A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

318

HTML

1861

Figures (1-4)

165

Sum=2344

Feb 21, 2007 (publication date) through May 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 21, 2007; 13(7): 1079-1084
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1079

Full Size Figure Download Figure

Figure 3 Tmax obtained in control subjects (A) and Crohn’s disease patients (B) using serum TUDCA and ¹³CO₂ breath tests.

Citation: Roda A, Simoni P, Magliulo M, Nanni P, Baraldini M, Roda G, Roda E. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. World J Gastroenterol 2007; 13(7): 1079-1084
URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1079.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1079